- Revolutionary T-Cell Analysis Unveiled for Early Cancer Detection at AACR | Reports Serum Detect
- Cutting-edge Grant Helps Noze a Canadian Medical Startup Pave the Way in Tuberculosis Fight
- Medtronic Announces FDA Approval of Newest-generation Evolut TAVR System for Treatment of Symptomatic Severe Aortic Stenosis
- Bio-Rad Launches Validated Antibodies for Rare Cell and Circulating Tumor Cell Enumeration
- Owen Mumford Acquires Empelvic
Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States, Medical Device News Magazine has established itself as one of the foremost and most trusted sources of comprehensive updates and insights within the medical device and biotech industries. Our publication is committed to delivering timely and relevant information, making it a go-to resource for professionals and enthusiasts alike.
Medical Device News Magazine is easily accessible to readers 24/7/365, allowing you to stay informed at your convenience, and it presents content that is a fast and engaging read. We take pride in offering valuable insights in a format that can be consumed quickly, ensuring that our audience stays ahead of the curve.
Furthermore, if you are interested in expanding your reach and visibility within this dynamic field, we encourage you to inquire about advertising opportunities with us.
"Medical Device and Biotechnology Sector News: Essential Key Insights and Noteworthy Developments that are Shaping the Future"
UroMems Announces First-Ever Smart Artificial Urinary Sphincter Implant in a Female Patient
This milestone indicates a new era for millions of women suffering from SUI, and results of this clinical study will contribute to the design and implementation of UroMems’ pivotal clinical trial in Europe and the U.S.
Glasgow Company’s Lifesaving Technology for Less Invasive Heart Surgery Making International Mark
A Glasgow-based company focused on less invasive heart surgery treatment of structural heart disease is making its mark on the international stage.
Kidd & Company, LLC Exits NextPhase Medical Devices, LLC
Kidd & Company advises NextPhase is a class II and III medical device contract manufacturer of complex electromechanical devices, active implantable devices and single use disposables in North America. It provides design and engineering, manufacturing and assembly, quality and regulatory, and supply chain and logistics management services enabling its customers to bring low-to-medium volume complex medical devices to market.
CMS Establishes HCPCS code for Ultromics EchoGo ® Heart Failure, Accelerating Access to Precision HFpEF Detection
Ultromics EchoGo ® Heart Failure is the first US Food and Drug Administration (FDA) cleared platform for detecting Heart Failure with Preserved Ejection Fraction (HFpEF), using a single view of an echocardiogram. The platform has the potential to catch disease earlier and get more patients on the pathway to treatment.
Innovative Solutions for Today's Challenges, Secured Funding for a Brighter Future
Cardiac Dimensions Raises $35M in Series D Round
Cardiac Dimensions reports financing was co-led by existing investor Horizon 3 Healthcare and an undisclosed strategic investor, with all other existing investors participating, including Arboretum Ventures, Hostplus, EQT Life Sciences (formerly LSP), Lumira Ventures, and M. H. Carnegie & Co.
Whisker Sells One Millionth Robot and Completes Its $10M USA Manufacturing Expansion
The Litter-Robot 4 was meticulously designed by the Whisker Team, taking more than 20 years of product innovation and experience into consideration.
Industry Expert Byline
Reimagining CRM: What’s Next for Medtech Commercial Success | By Akshay Kapadia, CEO and Founder, Conexus Solutions, Inc.
Success depends on more than just choosing the right CRM platform; it requires aligning that platform with optimized business processes, a clear data strategy, and long-term commercial goals. When all of these elements work together, the CRM platform becomes a powerful tool to support growth, innovation, and sustained value.
Amgen Provides Regulatory Update on the Status of Lumakras® (Sotorasib)
This review, which resulted in a Complete Response Letter, was based on the CodeBreaK 200 trial results for the treatment of adults with previously treated locally advanced or metastatic KRAS G12C-mutated non-small cell lung cancer. The FDA also issued a new postmarketing requirement for an additional confirmatory study to support full approval that will be completed no later than February 2028.
BrainStorm Granted Patents for Allogeneic Exosome Platform-Product in Neurological Disorder Treatments
The Australian patent Office granted patent No. 2019252987 titled ‘Cell-Type Specific Exosomes and Use Thereof’ for an isolated Exosomes population derived from MSC-NTF cells as well as a pharmaceutical composition for the treatment of neurodegenerative diseases.
Comprehensive Insights into Medical Device and Biotechnology Company Mergers and Acquisitions Trends and Strategies
Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion
CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”
Cardio Partners, a Sarnova company, Acquires Allied 100
The combination of companies expands access to sudden cardiac arrest (SCA) preparedness solutions to customers nationwide.
FDA Medical Device Updates
Our Experts - Byline Articles
Medical Imaging Technologies and Their Impact on Modern Healthcare
Healing Headlines, Transforming Lives: Hospitals in the News
Lunit Makes Full-Fledged Entry into the Middle East with Participation in ‘Saudi Vision 2030’ Healthcare Transformation Project
The partnership seeks to contribute to driving healthcare transformation across Saudi Arabia, aligning with the Kingdom’s ‘Saudi Vision 2030’ strategy.
